2-Pyrrolidinone moiety is not critical for the cognition-enhancing activity of piracetam-like drugs

Author： Scapecchi S.   Martelli C.   Ghelardini C.   Guandalini L.   Martini E.   Gualtieri F.  

Publisher： Elsevier

ISSN： 0014-827X

Source： Il Farmaco, Vol.58, Iss.9, 2003-09, pp. : 715-722

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Design and Study of Piracetam-like Nootropics, Controversial Members of the Problematic Class of Cognition-Enhancing Drugs

By  

Current Pharmaceutical Design, Vol. 8, Iss. 2, 2002-01 ,pp. : 125-138

Bentham Science Publishers

Access to resources Recommend Favorite

Piracetam and Piracetam-Like Drugs: From Basic Science to Novel Clinical Applications to CNS Disorders

By Malykh Andrei G.   Sadaie M. Reza  

Drugs, Vol. 70, Iss. 3, 2010-02 ,pp. : 287-312

Adis International

Access to resources Recommend Favorite

Memory Assessment in Studies of Cognition-Enhancing Drugs for Alzheimer's Disease

By Simard M.   van Reekum R.  

Drugs & Aging, Vol. 14, Iss. 3, 1999-03 ,pp. : 197-230

Adis International

Access to resources Recommend Favorite

Cognition-Enhancing Drugs in Mild Cognitive Impairment (MCI) and Alzheimer's Disease (AD): An Update [1]

By  

Medicinal Chemistry Reviews - Online, Vol. 2, Iss. 6, 2005-12 ,pp. : 471-487

Bentham Science Publishers

Access to resources Recommend Favorite

The Psychopharmacology of European Herbs with Cognition-Enhancing Properties

By  

Current Pharmaceutical Design, Vol. 12, Iss. 35, 2006-12 ,pp. : 4613-4623

Bentham Science Publishers

Access to resources Recommend Favorite